Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

InsuLearn Feasibility With Type 1 Diabetes Patients Under MDI Therapy

NCT: NCT06411548 · COMPLETED

NCT IDNCT06411548
StatusCOMPLETED
Start Date2025-03-27
Completion2025-10-17
SponsorUniversity of Virginia (OTHER)
First posted
Last updated

Brief Summary

This is a 24-hour, randomized, crossover, single-center trial where participants are randomized to either start with the InsuLearn intervention or the usual care (UC) intervention. In the InsuLearn intervention, insulin doses are optimized using data collected in a 4-weeks at home data collection period.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑